Funding
Our milestone-based funding approach allows us to efficiently allocate capital while ensuring that development constantly progresses.
Enabling innovation
Leveraging proprietary technology to accelerate drug discovery, reposition existing molecules with big data approaches, and improve patient outcomes with digital therapeutics.
JOIN OUR MAILING LIST
Sign up to receive the latest news on atai.
Email